Cargando…
20(S)-Protopanaxatriol promotes the binding of P53 and DNA to regulate the antitumor network via multiomic analysis
Although the tumor suppressor P53 is known to regulate a broad network of signaling pathways, it is still unclear how certain drugs influence these P53 signaling networks. Here, we used a comprehensive single-cell multiomics view of the effects of ginsenosides on cancer cells. Transcriptome and prot...
Autores principales: | Wang, Zhihua, Wu, Wenbo, Guan, Xiangchen, Guo, Shuang, Li, Chaowen, Niu, Ruixue, Gao, Jie, Jiang, Min, Bai, Liping, Leung, Elaine Laihan, Hou, Yuanyuan, Jiang, Zhihong, Bai, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332671/ https://www.ncbi.nlm.nih.gov/pubmed/32642409 http://dx.doi.org/10.1016/j.apsb.2020.01.017 |
Ejemplares similares
-
Computational and experimental characterization of estrogenic activities of 20(S, R)-protopanaxadiol and 20(S, R)-protopanaxatriol
por: Zhang, Tiehua, et al.
Publicado: (2020) -
Complete conversion of all typical glycosylated protopanaxatriol ginsenosides to aglycon protopanaxatriol by combined bacterial β-glycosidases
por: Yang, Eun-Joo, et al.
Publicado: (2018) -
20(S)-Protopanaxatriol inhibits release of inflammatory mediators in immunoglobulin E-mediated mast cell activation
por: Kim, Dae Yong, et al.
Publicado: (2015) -
Potential Dissociative Glucocorticoid Receptor Activity for Protopanaxadiol and Protopanaxatriol
por: Karra, Aikaterini G., et al.
Publicado: (2018) -
Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites
por: Chen, Xiao-Jia, et al.
Publicado: (2016)